期刊文献+

肝素微胶囊的制备及其性能研究 被引量:2

Preparation and property of heparin microcapsule
下载PDF
导出
摘要 本研究利用壳聚糖与海藻酸钠为囊材,借助油包水(w/o)乳化交联技术制备了新型肝素微胶囊,并对其性能进行了系统性的研究。研究结果表明随着微胶囊中壳聚糖的含量的增加,肝素在胶囊里面的包封率增大,而释放速率则降低。当微囊中的壳聚糖含量达到20%(wt)时,肝素的包封率可以达到58%。 The preparation method of heparin microcapsule has been researched in this work. As we have known, a lot of synthesis and natural polymer have been used in preparation of microcapsule. The chitosan and sodium alginate have been selected as microcapsule materials in this work because of their excellent biodegradability and biocompatibility. The results of this research showed that the envelope efficiency of heparin in microcapsules increase and the release speed of heparin decrease with the increasing of chitosan content in microcapsule. The envelope efficiency is about 58% when microcapsule containing 20%(wt) of chitosan.
出处 《广东药学》 CAS 2004年第5期25-28,共4页 Guangdong Pharmaceutical Journal
基金 国家自然科学基金资助项目(NO.39970213) "973"(G1999054303) "863"(2001AA625050-1) 广东省重大专项资助项目(A3020104)
关键词 肝素 微胶囊 壳聚糖 海藻酸钠 Heparin Microcapsule Chitosan Sodium alginate
  • 相关文献

参考文献11

  • 1丁明,施建军,皇甫立霞,高建锋.壳聚糖微球的制备研究[J].化学世界,1998,39(12):636-640. 被引量:34
  • 2舒晓正,朱康杰.壳聚糖─海藻酸钠微囊对蛋白质控制释放的研究[J].功能高分子学报,1999,12(4):423-426. 被引量:35
  • 3李立华,屠美,莫文军,周长忍.聚硅氧烷/液晶复合膜的制备及其血液相容性研究[J].功能高分子学报,2000,13(2):133-136. 被引量:11
  • 4David J.Tyrell,Stephen Kilfeather and Clive P.Page.Therapeutic uses of heparin beyond its traditional role as an anticoagulant[J].Trands in Pharmacological Sciences,1995,16(6):198-204.
  • 5Armin Breitenbach,You Xin Li and Thomas Kissel.Branched biodegradable polyesters for parenteral drug delivery systems[J].Journal of Controlled Release,2000,64:167-178.
  • 6Venu Menon,Scott D.Berkowitz,Elliott M.Antman,etc.New Heparin Dosing Recommendations for Patients with Acute Coronary Syndromes[J].The American Journal of Medicine,2001,110:641-649.
  • 7Zhou C R,Yi Z.Blood-compatibility of polyurethane/liquid crystal composite membranes[J].Biomaterials,1999;20:2093.
  • 8Lihua L,Wenjun M,Changren ZH.Preparation and Blood-compatibility of Polysiloxane/Liquid Crystal Composite Membranes[J].Biomaterials,2001;22:2595.
  • 9Smith PK,Mallia A K,Hermanson G T.Colorimetric Method for the Assay of Heparin Content in Immobilized Heparin Preparations[J].Aanalytical Biochemistry,1980,109:466-473.
  • 10Eliana Leo,Flavio Forni and Maria Teresa Bernabei.Surface drug removal from ibuprofen-loaded PLA microsheres[J].International Journal of Pharmaceutics,2000,196:1-9.

二级参考文献11

共引文献84

同被引文献13

  • 1梁振鹏,王朝阳,孙启龙,童真.LbL层层纳米自组装法制备新型微胶囊[J].化学进展,2004,16(4):485-491. 被引量:26
  • 2张天民,崔慧斐,王凤山,罗振,李华,王福清,杨立波,李素霞,沈渤江.高抗血栓活性的低分子肝素[J].中国医药工业杂志,1994,25(7):301-309. 被引量:38
  • 3曾凡彬,陆彬,杨红,邓希贤.盐酸川芎嗪肺靶向微球的研究[J].药学学报,1996,31(2):132-137. 被引量:50
  • 4TYNER K M, SCHIFFMAN S R, GIANNELIS E P. Nanobiohybrids as delivery vehicles for camptothecin [J]. Journal of Controlled Release, 2004, 95(3) : 501 -514.
  • 5Zhang Y, WANG C C, YANG W L, et al. Tri-component diblock copolymers of poly (ethylene glycol )-poly (a-caprolactone-colactide) : synthesis, charact-erization and loading camptothecin[ J ]. Colloid Polymer Science, 2005, 283(11) : 1246 - 1252.
  • 6QIU X P, LEPORATTI S, DONATH E, et al. Studies on the drug release properties of polysaccharide multilayers encapsulated ibuprofen microparticles [ J ]. Langmuir, 2001, 17(17) :5375 -5380.
  • 7DAI Z F, HEIHG A, ZASTROW H, et al. Novel formulations of vitamins and insulin by nanoengineering of polyelectrolyte multilayers around microcrystals [ J ]. Chemistry - A European Journal, 2004, 10(24) : 6369 -6374.
  • 8Rao J, Ramesh D, Rao K. Controlled-release Systems for proteins based on gelatin microspheres[ J]. J Biomat Sci Polym E, 1994,6 ( 5 ) : 391- 398.
  • 9Illum L, Davis S S. The targeting of drugs parenterally by use of microsph [ J]. J Parenter Sci Technol, 1986,36 ( 1 ) : 242-246.
  • 10路伟,王亮明,李朝今.肝素钠明胶微球的制备工艺研究[J].中国生化药物杂志,1998,19(3):136-138. 被引量:11

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部